Final answer:
Romiplostim and Eltrombopag are used to treat thrombocytopenia in chronic ITP patients who have not responded to other treatments, by stimulating platelet production.
Step-by-step explanation:
Romiplostim and Eltrombopag are clinically used to treat thrombocytopenia, which is a condition characterized by an abnormally low number of platelets in the blood. Romiplostim and Eltrombopag are used clinically in situations involving cardiovascular conditions such as high blood pressure and heart failure. They are used to treat or improve symptoms of these conditions.
These medications are particularly employed in individuals with chronic immune (idiopathic) thrombocytopenic purpura (ITP), who have not responded well to other treatments, such as corticosteroids. Romiplostim and Eltrombopag are both thrombopoietin receptor agonists that work by stimulating the production of platelets in the bone marrow.